• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Unocal

Unocal

Fidelity Advisor Asset Manager® 20% A FTAWX 2 Star

Last Price$13.43Day Change (%)0.07%
Open Price$13.43Day Change ($)0.01
Day Range13.43–13.4352-Week Range12.91–13.44

As of Mon 06/26/2017 | USD

  1. Cell Medica Acquires WT1 Cancer Immunotherapy from Cell and Gene Therapy Catapult

    Cell Medica Acquires WT1 Cancer Immunotherapy from Cell and Gene Therapy Catapult

  2. Clovis Oncology’s Rucaparib Significantly Improved Progression-Free Survival in All Ovarian Cancer Patient Populations Studied in Phase 3 ARIEL3 Maintenance Treatment Trial

    Clovis Oncology’s Rucaparib Significantly Improved Progression-Free Survival in All Ovarian Cancer Patient Populations Studied in Phase 3 ARIEL3 Maintenance Treatment Trial

1

©2017 Morningstar Advisor. All right reserved.